Eyeworld Daily News

EW SHOW DAILY 24 by Cindy Sebrell ASCRS•ASOA Director of Public Affairs Latest inductees to the ASCRS Hall of Fame A leader in Japanese oph- thalmology and a pioneer in modern cataract sur- gery will be inducted into the Ophthalmology Hall of Fame at today's ASCRS Sympo- sium Opening General Session. Saiichi Mishima, MD, and Richard Kratz, MD, will be hon- ored. Dr. Mishima, who is now deceased, was a leader of Japanese ophthalmology. He was born in 1927 in Osaka, Japan. He entered the prestigious Tokyo University Medical School in 1945, where he began his ophthalmology training a year later, followed by academic positions at Kanto Teishin Hospital and Tokyo Medical and Dental Uni- versity. In 1959, Dr. Mishima was awarded a year-long scholarship to the Institute of Ophthalmology in London, where he studied the fluid regulation in the cornea and its im- plications with David Maurice, PhD, a leading experimentalist in the field. After returning to Tokyo Univer- sity for a year, Dr. Mishima headed to Boston for a two-year stint at the Cornea Unit of the Schepens Eye Research Institute—then named the Retina Foundation—to study the imbibition pressure of the corneal stroma. He spent another three years researching the corneal endothelium and its pump function at the Co- lumbia Presbyterian Hospital in New York City. In 1968, Dr. Mishima returned to Tokyo University. Three years later, he was appointed as full pro- fessor and chairman of the country's foremost ophthalmology depart- ment. He was elected by his col- leagues to leadership roles in professional organizations, includ- ing president of the Japanese Oph- thalmologic Society; director and dean of the Faculty of Medicine, Tokyo University Hospital; and sec- retary general of the 1978 Interna- tional Congress. In the early 1980s at Schepens Eye Research Institute, Dr. Mishima, in collaboration with Richard A. Thoft, MD, established the concept of centripetal movement of the corneal epithelium. His groundbreaking work shed new light on the importance of the limbal epithelium. His series of findings have had an enormous impact on this subject, ultimately contributing to the devel- opment of the corneal stem cell the- ory. In 1987, Dr. Mishima retired from chairmanship at Tokyo Univer- sity and became director of the Tokyo Kosei-Nenkin Hospital, a posi- tion he held for 10 years. He also continued his scholarship, produc- ing "The History of Ophthalmology in Japan" and "International Biogra- phy and Bibliography of Ophthal- mologists and Vision Scientists." During the past 30 years, Dr. Mishima's primary focus was the research and development of new therapeutic modalities for the cornea. Following this path, his group recently established the sys- tem of cultivated mucosal epithelial stem cell transplantation and culti- vated corneal endothelial transplan- tation. Dr. Kratz received his bachelor's degree from Occidental College in 1942 and his MD from the Univer- sity of Southern California in 1946. He was chief of ophthalmology and ENT in the U.S. Army 49th General Hospital in Tokyo, Japan, finishing in 1947. Dr. Kratz took the Diploma in Ophthalmic Medicine and Sur- gery course at Moorfields Hospital in 1948, where he studied directly under Harold Ridley. He finished the ophthalmology and ENT residency at Duke University, Durham, N.C., in 1951. Dr. Kratz is or has been a mem- ber of 15 ophthalmological societies and is a founding member of ASCRS, the Contact Lens Association of Ophthalmologists, the Joint Com- mission on Allied Health Personnel in Ophthalmology, and the National Ophthalmological Society. He has served as president, chairman, or board member of several societies and has received numerous awards and given many honorary lectures. In 1965, Dr. Kratz testified at the U.S. Senate hearing and helped defeat the bill sponsored by op- tometrists and opticians that would have made it illegal for an ophthal- mologist to fit contact lenses or glasses and required patients to go to an optometrist for that service. Dr. Kratz is best known for de- veloping, teaching, and defending phacoemulsification against Medicare, the U.S. Food and Drug Administration, and some of the senior academic ophthalmologists. He is co-founder with Robert Sinskey, MD, of the course that taught the phaco technique to about 4,000 ophthalmologists from all over the world. The course simpli- fied the procedure by moving the emulsification from the anterior chamber to the iris plane to protect the corneal endothelium. Dr. Kratz and Dr. Sinskey developed the two- handed technique, the scleral tunnel incision, hydrodissection of the nu- cleus, and polishing of the posterior capsule. They also made many mod- ifications of the phaco machine and surgical instruments. Dr. Kratz is clinical professor emeritus of ophthalmology at the University of Southern California, Los Angeles, and the University of California, Irvine. He has never patented any of the intraocular lenses, devices, or instruments that he developed and declined the honor of being chairman of oph- thalmology at the University of California. The Ophthalmology Hall of Fame was created by ASCRS in 1999 to honor pioneers such as these with an ongoing celebration of their distinguished careers and contribu- tions. The Ophthalmology Hall of Fame Exhibit opens immediately fol- lowing the ASCRS Opening General Session and will be available for viewing during the meeting. EW Saturday, April 20, 2013 ASCRS News Today Richard Kratz, MD Saiichi Mishima, MD Physicians Courses • 21-209 4/21 10:00-11:30 a.m. Faculty: Sven C. Beutelspacher, MD • 22-103 4/22 8:00-9:30 a.m. Faculty: Antonio F. Motta, MD • 22-403 4/22 3:00-4:30 p.m. Faculty: Michael D. Straiko, MD • 23-105 4/23 8:00-9:30 a.m. Faculty: George O. Waring IV, MD Posters • Poster Judge: John Marshall, PhD • P210: Quality of Vision and Pa- tient Satisfaction After Wavefront- Guided and Wavefront-Optimized PRK Coauthor: Joseph F. Pasternak, MD continued from page 22

• Cover